Stanley S. Franklin

17.9k total citations · 6 hit papers
137 papers, 12.6k citations indexed

About

Stanley S. Franklin is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, Stanley S. Franklin has authored 137 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Cardiology and Cardiovascular Medicine, 44 papers in Endocrinology, Diabetes and Metabolism and 24 papers in Nutrition and Dietetics. Recurrent topics in Stanley S. Franklin's work include Blood Pressure and Hypertension Studies (84 papers), Cardiovascular Health and Disease Prevention (54 papers) and Hormonal Regulation and Hypertension (30 papers). Stanley S. Franklin is often cited by papers focused on Blood Pressure and Hypertension Studies (84 papers), Cardiovascular Health and Disease Prevention (54 papers) and Hormonal Regulation and Hypertension (30 papers). Stanley S. Franklin collaborates with scholars based in United States, United Kingdom and Italy. Stanley S. Franklin's co-authors include Martin G. Larson, Daniel Levy, Nathan D. Wong, Nathan D. Wong, Shehzad Akbar Khan, William B. Kannel, Gilbert L’Italien, Jose R. Pio, Michael A. Weber and Ian B. Wilkinson and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Stanley S. Franklin

135 papers receiving 11.9k citations

Hit Papers

Hemodynamic Patterns of Age-Related Changes in Blood Pres... 1997 2026 2006 2016 1997 2004 1999 2001 2001 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanley S. Franklin United States 49 8.8k 2.7k 1.8k 1.4k 1.3k 137 12.6k
Christopher J. Bulpitt United Kingdom 55 8.9k 1.0× 3.1k 1.1× 1.7k 0.9× 2.0k 1.4× 1.1k 0.8× 187 15.2k
Suzanne Oparil United States 26 9.5k 1.1× 3.4k 1.2× 1.7k 0.9× 1.9k 1.4× 801 0.6× 50 14.2k
Barry J. Materson United States 32 9.9k 1.1× 3.6k 1.3× 1.7k 0.9× 1.8k 1.3× 936 0.7× 109 15.3k
Renata Cífková Czechia 37 7.9k 0.9× 2.5k 0.9× 1.8k 1.0× 1.3k 1.0× 1.1k 0.8× 217 12.3k
Thomas D. Giles United States 40 6.3k 0.7× 2.3k 0.8× 1.6k 0.9× 1.1k 0.8× 1.2k 0.9× 288 10.9k
Jeffrey L. Probstfield United States 44 6.6k 0.8× 4.4k 1.6× 3.3k 1.8× 1.1k 0.8× 1.3k 1.0× 148 12.2k
Hans Ibsen Denmark 49 12.4k 1.4× 4.3k 1.6× 2.1k 1.2× 1.4k 1.0× 1.4k 1.1× 261 16.8k
Anthony M. Heagerty United Kingdom 56 10.4k 1.2× 3.0k 1.1× 3.0k 1.6× 1.5k 1.1× 1.3k 1.0× 280 15.9k
Giuseppe Schillaci Italy 62 11.7k 1.3× 2.3k 0.8× 2.7k 1.5× 1.2k 0.9× 1.6k 1.2× 217 16.4k
Ehud Grossman Israel 54 5.2k 0.6× 2.2k 0.8× 1.5k 0.8× 848 0.6× 826 0.6× 400 10.3k

Countries citing papers authored by Stanley S. Franklin

Since Specialization
Citations

This map shows the geographic impact of Stanley S. Franklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley S. Franklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley S. Franklin more than expected).

Fields of papers citing papers by Stanley S. Franklin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley S. Franklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley S. Franklin. The network helps show where Stanley S. Franklin may publish in the future.

Co-authorship network of co-authors of Stanley S. Franklin

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley S. Franklin. A scholar is included among the top collaborators of Stanley S. Franklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley S. Franklin. Stanley S. Franklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yano, Yuichiro, Jeremiah Stamler, Daniel B. Garside, et al.. (2015). Isolated Systolic Hypertension in Young and Middle-Aged Adults and 31-Year Risk for Cardiovascular Mortality. Journal of the American College of Cardiology. 65(4). 327–335. 151 indexed citations
2.
Wong, Nathan D., Diana Glovaci, Shaista Malik, et al.. (2012). Global cardiovascular disease risk assessment in United States adults with diabetes. Diabetes and Vascular Disease Research. 9(2). 146–152. 50 indexed citations
3.
Gluba-Brzózka, Anna, Agata Bielecka‐Dąbrowa, Nathan D. Wong, et al.. (2012). An update on biomarkers of heart failure in hypertensive patients. Journal of Hypertension. 30(9). 1681–1689. 44 indexed citations
4.
Schillaci, Giuseppe, Giacomo Pucci, Matteo Pirro, et al.. (2011). Combined effects of office and 24-h blood pressure on aortic stiffness in human hypertension. Journal of Hypertension. 29(5). 869–875. 32 indexed citations
5.
Franklin, Stanley S.. (2010). Isolated systolic hypertension and the J-curve of cardiovascular disease risk☆. Artery Research. 4(1). 1–1. 9 indexed citations
6.
Franklin, Stanley S. & Joel M. Neutel. (2010). Efficacy and Safety of Irbesartan/HCTZ in Severe Hypertension According to Cardiometabolic Factors. Journal of Clinical Hypertension. 12(7). 487–494. 4 indexed citations
7.
Moser, Marvin, Stanley S. Franklin, & Joel Handler. (2007). The Nonpharmacologic Treatment of Hypertension: How Effective Is It?An Update. Journal of Clinical Hypertension. 9(3). 209–216. 4 indexed citations
8.
NEUTEL, J, Stanley S. Franklin, Pablo Lapuerta, Amitabha Bhaumik, & Agata Ptaszynska. (2007). A comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension. Journal of Human Hypertension. 22(4). 266–274. 28 indexed citations
9.
López, Víctor A., Stanley S. Franklin, Simon Tang, & Nathan D. Wong. (2007). Coronary Heart Disease Events Preventable by Control of Blood Pressure and Lipids in US Adults With Hypertension. Journal of Clinical Hypertension. 9(6). 436–443. 18 indexed citations
10.
Franklin, Stanley S., Jose R. Pio, Nathan D. Wong, et al.. (2005). Predictors of New-Onset Diastolic and Systolic Hypertension. Circulation. 111(9). 1121–1127. 185 indexed citations
11.
Schillaci, Giuseppe, Matteo Pirro, Gaetano Vaudo, et al.. (2005). Metabolic Syndrome Is Associated With Aortic Stiffness in Untreated Essential Hypertension. Hypertension. 45(6). 1078–1082. 126 indexed citations
12.
Klassen, Preston, et al.. (2005). Systolic hypertension: An overview. American Heart Journal. 149(5). 769–775. 8 indexed citations
13.
Nawrot, Tim S., Jan A. Staessen, Lutgarde Thijs, et al.. (2004). Should pulse pressure become part of the Framingham risk score?. Journal of Human Hypertension. 18(4). 279–286. 24 indexed citations
14.
Wong, Nathan D., Jose R. Pio, Stanley S. Franklin, et al.. (2003). Preventing coronary events by control of lipids and blood pressure in persons with the metabolic syndrome. Journal of the American College of Cardiology. 41(6). 268–268. 2 indexed citations
15.
Borghi, Claudio, Ada Dormi, Gilbert L’Italien, et al.. (2003). The Relationship Between Systolic Blood Pressure and Cardiovascular Risk—Results of the Brisighella Heart Study. Journal of Clinical Hypertension. 5(1). 47–52. 39 indexed citations
16.
Whyte, Joanna L., Pablo Lapuerta, Gilbert L’Italien, & Stanley S. Franklin. (2001). The Challenge of Controlling Systolic Blood Pressure: Data from the National Health and Nutrition Examination Survey (NHANES III), 1988–1994. Journal of Clinical Hypertension. 3(4). 211–216. 33 indexed citations
17.
Franklin, Stanley S. & Amanda N. Stephens. (2000). Can wine tasting be used as a defence to a charge of excess alcohol?. Science & Justice. 40(1). 39–40. 1 indexed citations
18.
Franklin, Stanley S., Shehzad Akbar Khan, Nathan D. Wong, Martin G. Larson, & Daniel Levy. (1999). Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease?. Circulation. 100(4). 354–360. 1331 indexed citations breakdown →
19.
Noguchi, Thomas T., et al.. (1975). Fatal Accidental Diglycolic Acid Intoxication. 3(4). 3–13. 11 indexed citations
20.
Franklin, Stanley S. & Morton H. Maxwell. (1975). Clinical Work-Up For Renovascular Hypertension. Urologic Clinics of North America. 2(2). 301–310. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026